• Subscribe
  • Magazine
  • Videos
  • Advertise
  • About Us
  • Smart Water Summit
  • Wastewater Summit
    • Recent Quotes
    My Watchlist
    Indicators
    WaterWorld Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Nuvalent Inc Cl A (NQ: NUVL )

    86.88 -3.30 (-3.66%)
    Streaming Delayed Price Updated: 4:00 PM EST, Nov 15, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 772,969
    Open 89.98
    Bid (Size) 34.81 (2)
    Ask (Size) 91.65 (1)
    Prev. Close 90.18
    Today's Range 86.43 - 89.98
    52wk Range 56.52 - 113.51
    Shares Outstanding N/A
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    From Nuvalent to Nuvectis Pharma: New Report Highlights NXP900's Synergy in NSCLC and Anticipated NXP800 Data Update
    The report covers Nuvectis (NASDAQ: NVCT) alongside notable similar precision oncology players such as Nuvalent ($6.6B) and Summit Therapeutics ($15B). 
    Via News Direct
    Bausch & Lomb And Edgewise Therapeutics Are Among Top 7 Mid Cap Stock Gainers Last Week (Sept 15-Sept 21): Are The Others In Your Portfolio?
    Federal Reserve's rate cut boosted tech, construction, industrial, machinery, and financial sectors. Top-performing mid-cap stocks last week. 
    Via Benzinga
    Topics Economy
    Exposures Interest Rates

    Performance

    YTD
    +14.17%
    +14.17%
    1 Month
    -17.11%
    -17.11%
    3 Month
    +21.41%
    +21.41%
    6 Month
    +22.57%
    +22.57%
    1 Year
    +49.72%
    +49.72%

    More News

    Read More
    Why Nuvalent (NUVL) Shares Are Down 6% Today
    Via Benzinga
    Nuvalent Stock Jumps On ESMO Data Presentation, Seeks To Raise $350M Via Equity
    Via Benzinga
    Nuvalent Flies On 'Multibillion-Dollar' Potential, While Iteos Crashes On Patient Deaths
    Via Investor's Business Daily
    Topics Death
    Exposures Death
    NUVL Stock Earnings: Nuvalent Misses EPS for Q2 2024
    Via InvestorPlace
    NUVL Stock Earnings: Nuvalent Misses EPS for Q1 2024
    Via InvestorPlace
    Crude Oil Surges Over 1%; Instil Bio Shares Plunge
    Via Benzinga
    Exposures Fossil Fuels
    Alcoa, Lattice Semiconductor, Stratasys And Other Big Stocks Moving Higher On Monday
    Via Benzinga
    Lucid, Grifols And Amer Sports Are Among Top 8 Mid Cap Stock Gainers Last Week (Aug 18-Aug 24): Are The Others In Your Portfolio?
    Via Benzinga
    3 Short-Squeeze Stocks Poised for a Jaw-Dropping Rally
    Via InvestorPlace
    Novavax And Agios Pharmaceuticals Were Among The 10 Biggest Mid-Cap Gainers Last Week (June 1-June 7): Are These In Your Portfolio?
    Via Benzinga
    Recap: Nuvalent Q4 Earnings
    Via Benzinga
    Recap: Nuvalent Q3 Earnings
    Via Benzinga
    7 Biotech Stocks to Get In Now Before Investors Catch On
    Via InvestorPlace
    Why Nuvalent Stock Tanked on Tuesday
    Via The Motley Fool
    Benzinga's 'Stock Whisper' Index: 5 Stocks Investors Are Secretly Monitoring But Not Talking About Yet
    Via Benzinga
    Why Nuvalent Stock Skyrocketed 35% This Week
    Via The Motley Fool
    Where Nuvalent Stands With Analysts
    Via Benzinga
    Why Nuvalent Stock Was Soaring Wednesday
    Via The Motley Fool
    12 Health Care Stocks Moving In Wednesday's Intraday Session
    Via Benzinga
    Challenging Road Ahead for Cancer Drugs, Nuvalent Seeks to Break the Mold
    Via Benzinga
    Benzinga's Top Ratings Upgrades, Downgrades For September 27, 2023
    Via Benzinga
    Why Nikola Shares Are Trading Higher By 33%? Here Are Other Stocks Moving In Monday's Mid-Day Session
    Via Benzinga
    Canopy Growth, DocGo And Other Big Stocks Moving Lower On Monday
    Via Benzinga
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.